Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The investigators hypothesized that consuming isolated yellow pea fibre or protein, alone to together, as part of a high-carbohydrate pasta meal, would reduce the blood glucose response to the meal compared to a meal without yellow pea components and reduce food intake at a meal served 2 hours later.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control | Active Comparator | Pasta meal with added fractions or control with no fractions Pasta meal with no pea fractions |
|
| 10 g protein | Experimental | Pasta meal with added fractions or control with no fractions 10 g net yellow pea protein added to pasta meal |
|
| 7 g yellow pea fibre | Experimental | Pasta meal with added fractions or control with no fractions 7 g net yellow pea fibre added to pasta meal |
|
| Yellow pea fibre & protein | Experimental | Pasta meal with added fractions or control with no fractions 10 g net yellow pea protein plus 7 g net yellow pea fibre added to pasta meal |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Pasta meal with added fractions or control with no fractions | Dietary Supplement |
|
| Measure | Description | Time Frame |
|---|---|---|
| Ad libitum food intake at second pizza meal | Food intake measured via electronic scale in g, then converted to kcal using the caloric density. | 135 mins after completion of treatment, 20 mins to eat pizza meal. |
| Blood glucose | Blood glucose measured via hand-held glucometer and finger prick. | between 0 and 215 mins, every 15-30 mins |
| Measure | Description | Time Frame |
|---|---|---|
| Subjective appetite | Measured via Visual Analog Scales (VAS) | 0 to 215 minutes |
| Measure | Description | Time Frame |
|---|---|---|
| Palatability of treatments | Measured by VAS to ensure palatability is not confounding other outcomes. | following treatment consumption at 15 mins |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Harvey G Anderson, PhD | University of Toronto | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Toronto - Department of Nutritional Sciences | Toronto | Ontario | M5S 3E2 | Canada | ||
| University of Toronto |
Not provided
| ID | Term |
|---|---|
| D009765 | Obesity |
| D003920 | Diabetes Mellitus |
| ID | Term |
|---|---|
| D050177 | Overweight |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Toronto |
| Ontario |
| M5S 3E2 |
| Canada |
| D001835 |
| Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D004700 | Endocrine System Diseases |